Ablavar Patent [Member]
Ablavar patent
Exclusive legal right granted by the government to exploit Ablavar for a period of time specified by law.
Ablavar
Accounts Payable Property, Plant and Equipment, Current
Accounts payable related to property, plant and equipment
Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for property, plant and equipment that are used in entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Freight Costs Current
Freight, distribution and operations
Carrying value as of the balance sheet date of obligations incurred through that date and payable for freight and distribution costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Liabilities [Line Items]
Accrued Expenses
Accrued Liabilities [Table]
Schedule of the components of accrued liabilities.
Accrued Loss on Contracts Due to Product Expiration
Accrued loss due to product expiration, associated with the portion of the committed purchases
Carrying value, as of the balance sheet date, of loss accrued due to product expiration.
Award Type [Axis]
Accrued Loss on Contracts Due to Product Expiration Current
Accrued loss due to product expiration, associated with the portion of the committed purchases, included in accrued expenses
Carrying value, as of the balance sheet date, of loss accrued due to product expiration. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued loss on firm purchase commitment
Accrued Loss on Contracts Due to Product Expiration Noncurrent
Accrued loss due to product expiration, associated with the portion of the committed purchases, included in other long-term liabilities
Carrying value, as of the balance sheet date, of loss accrued due to product expiration due after one year (or beyond the operating cycle if longer).
Accrued Rebates Discounts and Chargebacks Current
Accrued rebates, discounts and chargebacks
Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates, discounts and chargebacks. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Research and Development Costs Current
Research and development services
Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Amendment Description
Active Pharmaceutical Ingredient Agreement [Member]
API agreement
Represents information pertaining to agreement for Active Pharmaceutical Ingredient and finished products.
Amendment Flag
Additional Notes [Member]
Additional Notes
Represents the additional notes issued by the entity.
All Countries [Axis]
Represents the geopolitical areas recognized by governments of the world as a country.
AUSTRALIA
Australia
Amortization of consent fee
Amortization of Consent Fee
This element represents the amortization of consent solicitation fee during the reporting period where consent solicitation is an offer by the issuer of a security to change the terms of the security agreement. For example, a bond issuer may ask bondholders if the terms of the indenture may be changed. Consent solicitations are made because security agreements require mutual consent in order to be altered.
Capitalized consent fee
Represents the capitalized consent fee.
Capitalized Consent Solicitation Fee
Commitments
Guarantor Financial Information
Condensed Financial Information Disclosure [Text Block]
The entire disclosure of the condensed consolidating financial statements of the parent, issuer, guarantor and non-guarantor subsidiaries.
All Countries [Domain]
Debt Instrument Covenant Default Provisions Minimum Outstanding Indebtedness for Cross Acceleration
Minimum outstanding indebtedness required for cross acceleration under customary events of default provisions
Represents the minimum amount of outstanding indebtedness required for declaration as cross-acceleration under the default provisions under the covenants pertaining to debt instruments.
Debt Instrument Covenant Interest Coverage Ratio
Interest Coverage Ratio
Represents the ratio of adjusted earnings before interest, taxes, depreciation and amortization to interest expense, which is necessary to be maintained under the terms of the debt covenants.
Debt Instrument Covenant Leverage Ratio
Total Leverage Ratio
Represents the ratio of total debt to adjusted earnings before, interest, taxes, depreciation and amortization allowed under the terms of the debt covenants.
Debt Instrument Covenant Period after Quarter One 2014 [Member]
Thereafter
The period thereafter the first quarter of 2014.
Debt Instrument Covenant Period [Axis]
The periods over which the covenants are in effect.
Debt Instrument Covenant Period [Domain]
The period over which the covenants are in effect.
Debt Instrument Covenant Period Quarter Four 2011 [Member]
Q4 2011
The period representing the fourth quarter of 2011.
Debt Instrument Covenant Period Quarter Four 2012 [Member]
Q4 2012
The period representing the fourth quarter of 2012.
Debt Instrument Covenant Period Quarter Four 2013 [Member]
Q4 2013
The period representing the fourth quarter of 2013.
Debt Instrument Covenant Period Quarter One 2011 [Member]
Q1 2011
The period representing the first quarter of 2011.
Current Fiscal Year End Date
Debt Instrument Covenant Period Quarter One 2012 [Member]
Q1 2012
The period representing the first quarter of 2012.
Debt Instrument Covenant Period Quarter One 2013 [Member]
Q1 2013
The period representing the first quarter of 2013.
Debt Instrument Covenant Period Quarter One 2014 [Member]
Q1 2014
The period representing the first quarter of 2014.
Debt Instrument Covenant Period Quarter Three 2011 [Member]
Q3 2011
The period representing the third quarter of 2011.
Debt Instrument Covenant Period Quarter Three 2012 [Member]
Q3 2012
The period representing the third quarter of 2012.
Debt Instrument Covenant Period Quarter Three 2013 [Member]
Q3 2013
The period representing the third quarter of 2013.
Debt Instrument Covenant Period Quarter Two 2011 [Member]
Q2 2011
The period representing the second quarter of 2011.
Debt Instrument Covenant Period Quarter Two 2012 [Member]
Q2 2012
The period representing the second quarter of 2012.
Debt Instrument Covenant Period Quarter Two 2013 [Member]
Q2 2013
The period representing the second quarter of 2013.
Debt Instrument Issue Price as Percentage of Principal Amount
Issue price of debt instrument as a percentage of principal amount
Represents the debt instrument issuance price, expressed as a percentage of the principal amount of the debt instrument.
Debt Instrument Percentage of Original Principal Amount Outstanding after Redemption from Equity Offerings
Percentage of the principal amount of the debt instrument which must remain outstanding after the entity has redeemed a portion of the debt instrument with the proceeds from certain equity offerings
Represents the percentage of the original principal amount of the debt instrument that must remain outstanding after the entity has redeemed a portion of the debt instrument with net cash proceeds from certain equity offerings.
Document Period End Date
CANADA
Canada
Debt Instrument Redemption Period [Axis]
The periods over which the redemption price is in effect.
Debt Instrument Redemption Period [Domain]
The period over which the redemption price is in effect.
Debt Instrument Redemption Period Following Receipt of Proceeds from Equity Offerings
Redemption period for the entity to redeem the debt instrument following the receipt of cash proceeds from certain equity offerings
Represents the redemption period for the entity to redeem the debt instrument following the receipt of cash proceeds from certain equity offerings.
Debt Instrument Redemption Period on or after 15 May, 2016 [Member]
On or after May 15, 2016
The period on or after May 15, 2016.
Debt Instrument Redemption Period Prior to 15 May, 2013 [Member]
Prior to May 15, 2013
The period prior to May 15, 2013.
Debt Instrument Redemption Period Prior to 15 May, 2014 [Member]
Prior to May 15, 2014
The period prior to May 15, 2014.
The twelve month period beginning May 15, 2014.
Debt Instrument Redemption Period Twelve Month Period Beginning 15 May, 2014 [Member]
Twelve month period beginning May 15, 2014
Debt Instrument Redemption Period Twelve Month Period Beginning 15 May, 2015 [Member]
Twelve month period beginning May 15, 2015
The twelve month period beginning May 15, 2015.
Debt Instrument Redemption Price as Percentage of Principal Amount
Redemption price of debt instrument as a percentage of principal amount
Represents the redemption price of the debt instrument as a percentage of the principal amount.
Entity [Domain]
Debt Instrument Redemption Price upon Change of Control as Percentage of Principal Amount
Redemption price of debt instrument as a percentage of principal amount upon change of control
Represents the redemption price as a percentage of the principal amount at which the debt instrument may be required to be redeemed in the event of a change of control.
Debt Instrument Redemption Price with Net Proceeds from Equity Offerings as Percentage of Original Principal
Redemption price of the debt instrument if redeemed with the proceeds of certain equity offerings (as a percent)
Represents the redemption price of the debt instrument as a percentage of the principal amount if redeemed with net cash proceeds from certain equity offerings.
Percentage of the principal amount of the debt instrument which the entity may redeem with the proceeds from certain equity offerings (as a percent)
Represents the percentage of the original principal amount of the debt instrument that the entity may redeem with net cash proceeds from certain equity offerings.
Debt Instrument Redemption with Net Proceeds from Equity Offerings as Percentage of Original Principal
Debt Instrument Variable Rate Base [Axis]
The alternative reference rates that may be used to calculate the variable interest rate of the debt instrument.
Debt Instrument Variable Rate Base [Domain]
Identification of the reference rate that is used to calculate the variable interest rate of the debt instrument.
Debt Instrument Variable Rate Base LIBOR [Member]
LIBOR
The London Interbank Offered Rate (LIBOR) used to calculate the variable interest rate of the debt instrument.
Debt Instrument Variable Rate Base Reference Rate [Member]
Reference Rate
The Reference Rate used to calculate the variable interest rate of the debt instrument.
Property, plant and equipment included in accounts payable and accrued expenses
Represents the amount of decrease in accounts payable and accrued expenses for property, plant and equipment through non cash transactions.
Decrease in Accounts Payable and Accrued Expenses for Property Plant and Equipment
Demand Note [Member]
Demand note
Represent information pertaining to the demand note payable.
Document and Entity Information
Due from Related Parties Noncurrent Long Term Assets Reclassified to Equity
Outstanding receivable from Holdings
Represents the amounts due from related parties which were reclassified during the period from long-term assets to equity.
Due from parent (see Note 14)
Equity in other comprehensive income (loss) of subsidiaries
Represents the share of the parent entity in other comprehensive income (loss) of subsidiaries.
Equity in Other Comprehensive Income (Loss) of Subsidiaries
Existing Notes [Member]
Represents the notes previously issued by the entity.
Existing Notes
Represents the number of intangible assets whose estimated useful life has been revised during the period.
Finite Lived Intangible Asset Revision in Useful Life Number of Assets
Number of intangible assets whose estimated remaining useful life has been revised
Gain Contingency New Claims Filed Number
Number of suits filed
Represents the total number of new claims filed by the entity pertaining to a gain contingency during the period.
Gain (Loss) on Firm Purchase Commitment
Loss on firm purchase commitment
Represents gain loss on firm purchase commitment during the reporting period.
Inventory Current and Noncurrent
Total
Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances.
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of the noncurrent portion of merchandise or goods held by the company that are readily available for sale.
Inventory Finished Goods Noncurrent
Non-current finished goods
Inventory [Line Items]
Inventory
Non-current raw materials
Represents the noncurrent portion of unprocessed items to be consumed in the manufacturing or production process. Also includes purchased parts that will be used as components of a finished product.
Inventory Raw Materials Noncurrent
Represents the number of years of shelf life of finished goods.
Inventory Shelf Life
Aggregate inventory shelf life
Inventory [Table]
Detailed information about the type of inventory held by the entity.
Inventory write-down due to product expiration
Inventory Write Down due to Product Expiration
Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, attributable to product expiration.
Lantheus MI Holdings [Member]
Represents information pertaining to Lantheus MI Holdings, Inc., the parent of the reporting entity, Lantheus Intermediate.
Holdings
LMI
Unfunded Standby Letter of Credit face amount
The stated principal amount of the letters of credit before amendment.
Letter of Credit Outstanding Amount Before Amendment
Maximum borrowing capacity under standby letter of credit
Letters of Credit Maximum Borrowing Capacity
Represents the maximum borrowing capacity under the letters of credit.
Liability Award [Member]
Liability awards
Represents the information pertaining to the awards classified as liability by the entity.
Line of Credit Facility Maximum Available Increase in Maximum Borrowing Capacity
Maximum increase available in the aggregate borrowing capacity
Represents the maximum amount by which the maximum borrowing capacity under the line of credit facility can be increased.
Line of Credit Facility Payments for Amendment Fees
Fees associated with amendment
Represents the fees associated with the amendment under the line of credit facility.
Machinery Equipment and Fixtures [Member]
Machinery, equipment and fixtures
Represents the tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, fixtures.
Modified Stock Options [Member]
Modified stock options
Represents information pertaining to the modified contract that gives the holder the right, but not the obligation, either to purchase or to sell a certain number of shares of stock at a predetermined price for a specified period of time.
Number of Guarantor Subsidiaries
Number of guarantor subsidiaries
Represents the number of guarantor subsidiaries of the entity.
Number of Radiopharmacies Owned
Number of radiopharmacies owned
Represents the number of radiopharmacies owned by the entity.
One Trademark with Revised Estimate of Remaining Useful Life [Member]
One Trademark with revised estimate of remaining useful life
Single trademark for which the entity revised the estimated remaining useful life.
Organization Consolidation and Presentation of Financial Statements [Line Items]
Business Overview
Organization Consolidation and Presentation of Financial Statements [Table]
Schedule of organization, consolidation and presentation of financial statements.
Other Comprehensive Income (Loss) Tax Portion Attributable to Parent Excluding Foreign Currency Translation
Tax effect of the change in accumulated other comprehensive income, that is, the tax effect on items included in other comprehensive income that is attributable to the parent entity but excluding tax effect of the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity during the period.
Income tax expense related to items of other comprehensive (loss) income
Consent solicitation fee
Payment of Consent Solicitation Fee
The cash outflow on account of payment of consent solicitation fee during the reporting period where consent solicitation is an offer by the issuer of a security to change the terms of the security agreement. For example, a bond issuer may ask bondholders if the terms of the indenture may be changed. Consent solicitations are made because security agreements require mutual consent in order to be altered.
Cash payment to amend the Indenture to modify the restricted payment covenant
Performance Based Stock Options [Member]
Performance based stock options
Represents the performance-based stock options issued under the share-based compensation arrangements.
Prior Credit Agreement [Member]
Prior credit agreement
Represents information pertaining to the prior credit agreement.
Repurchase Of Preferred Stock Value
Represents the accreted value of the preferred stock repurchased.
Repurchase of Series A Preferred Stock
Revenue Recognition
Revenue Recognition
Revenue Recognition Disclosure [Text Block]
The entire disclosure for revenue recognition policies of the reporting entity.
Schedule of Debt Instrument Financial Covenants [Table Text Block]
Schedule of revolving credit facility financial covenants
Tabular disclosure of the financial covenants by period related to the revolving credit facility.
Summary of Significant Accounting Policies
Schedule of Debt Instrument Redemption Price [Table Text Block]
Schedule of redemption prices of notes based on a premium percentage on the principal
Tabular disclosure of redemption prices of the debt instrument, expressed as a percentage of the principal amount.
Schedule of Inventory [Table Text Block]
Schedule of inventory, classified in inventory or other long-term assets
Tabular disclosure of the carrying amount as of the balance sheet date of current and noncurrent merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production.
Entity Well-known Seasoned Issuer
Tabular disclosure of the components of property, plant and equipment.
Schedule of Property Plant and Equipment Components [Table Text Block]
Schedule of Property, plant and equipment, net
Entity Voluntary Filers
Segment Reporting Information Assets Percentage
Represent the assets from a single reportable segment as a percentage of consolidated assets.
Percentage of consolidated assets (as a percent)
Entity Current Reporting Status
Represent the revenue generated from a single reportable segment as a percentage of consolidated revenue.
Segment Reporting Information Revenue Percentage
Percentage of consolidated revenues (as a percent)
Entity Filer Category
Settlement and Mutual Release Agreement [Member]
Settlement Agreement
Represents information pertaining to the Settlement and Mutual Release Agreement.
Entity Public Float
Intercompany accounts receivable
Accounts Receivable, Related Parties, Current
Share Based Compensation Arrangement by Share Based Payment Award Fair Value Assumptions Period of Reference Rate for Risk Free Interest Rate
Period of U.S. Treasury rate at the date of the grant used as risk-free interest rate assumption
Represents the period of the reference rate used to determine risk-free interest rate assumption that is used in valuing an option on its own shares.
Entity Registrant Name
Share Based Compensation Arrangement by Share Based Payment Award Number of Agreements Effected
Number of agreements effected, which were modified
Represents the number of award agreements effected, which were modified by the entity during the reporting period.
Entity Central Index Key
Represents the number of award agreements modified by the entity during the reporting period.
Share Based Compensation Arrangement by Share Based Payment Award Number of Agreements Modified
Number of agreements modified
Share Based Compensation Arrangement by Share Based Payment Award Options Cancellations in Period
Options cancelled (in shares)
Represents the number of shares under options cancelled during the reporting period.
Share Based Compensation Arrangement by Share Based Payment Award Options Cancellations in Period Weighted Average Exercise Price
Options cancelled (in dollars per share)
Represents the weighted average price of options that were cancelled during the reporting period.
Share Based Compensation Arrangement by Share Based Payment Award Options Intrinsic Value [Abstract]
Aggregate Intrinsic Value
Entity Common Stock, Shares Outstanding
Share Based Compensation Arrangement by Share Based Payment Award Options Vested in Period
Number of awards vested (in shares)
Represents the number of share options (or share units), that vested during the reporting period.
Weighted Average Remaining Contractual Term
Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]
Share Based Compensation Arrangements by Share Based Payment Award Options Expiration Term
Contractual term
The period of time from the grant date until the time at which the share-based option award expires.
Spare parts
Spare Parts [Member]
Represents the tangible personal property used for repair or replacement of failed parts.
Tax Indemnification Income
Tax indemnification income
Represents the tax indemnification income earned during the period.
Tax indemnification (expense) income
Tax Indemnification Income Expense
Represents the amount of tax indemnification (expense) income during the period.
Time Based Stock Options [Member]
Time based stock options
Represents the time-based stock options issued under the share-based compensation arrangements.
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accrued Expenses
Document Fiscal Year Focus
Document Fiscal Period Focus
Intercompany accounts payable
Accounts Payable, Related Parties, Current
Legal Entity [Axis]
Document Type
Accounts receivable, net of allowance of $258 and $462
Accounts receivable, net
Accounts Receivable, Net, Current
Accounts payable
Accounts Payable, Current
PUERTO RICO
Puerto Rico
Accrued Professional Fees, Current
Accrued professional fees
UNITED STATES
U.S.
Income tax payable
Accrued Income Taxes, Current
Accrued Marketing Costs, Current
Marketing expense
Accrued expenses
Accrued Liabilities, Current
Accrued liabilities
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated depreciation
Accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss), Net of Tax
Additional Paid in Capital, Common Stock
Additional paid-in capital
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Amortization
Amortization
Adjustments to reconcile net loss to cash flow from operating activities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Stock-based compensation
Allocated Share-based Compensation Expense
Stock-based compensation expense/(benefit)
Accounts receivable, allowance (in dollars)
Allowance for Doubtful Accounts Receivable, Current
Amortization of Intangible Assets
Amortization expense
Amortization of Financing Costs
Amortization of debt related costs
Amortization of debt premium
Amortization of Debt Discount (Premium)
Asset Retirement Obligation, Accretion Expense
Accretion expenses
Asset Retirement Obligations
Asset Retirement Obligations, Noncurrent
Asset retirement obligation
Balance at the beginning of the period
Balance at the end of the period
Asset Retirement Obligation, Liabilities Incurred
Capitalization
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Reconciliation of the asset retirement obligations
Asset Retirement Obligations
Asset Retirement Obligation Disclosure [Text Block]
Net decrease due to changes in estimated future cash flows
Asset Retirement Obligation, Revision of Estimate
Assets, Fair Value Disclosure
Assets
Current assets
Assets, Current [Abstract]
Assets
Assets [Abstract]
Total current assets
Assets, Current
Total assets
Assets
Assets
Building [Member]
Buildings
Business Overview
Business Description and Basis of Presentation [Text Block]
Capitalized Computer Software, Net
Capitalized software development costs
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents
Cash
Cash on-hand
Cash [Member]
Cash-on-hand
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Total cash and cash equivalents
Cash and cash equivalents, carrying value
Cash and Cash Equivalents [Axis]
Cash and cash equivalents, fair value
Cash and Cash Equivalents, Fair Value Disclosure
Certificates of Deposit [Member]
Certificate of deposit
Commitments
Commitments and Contingencies Disclosure [Text Block]
Legal Proceedings and Contingencies
Commitments and contingencies (see Note 13)
Commitments and Contingencies
Common Stock
Common Stock [Member]
Common stock, share outstanding
Common Stock, Shares, Outstanding
Common stock ($0.001 par value, 10,000 shares authorized; 1 share issued and outstanding)
Common Stock, Value, Issued
Common stock, share issued
Common Stock, Shares, Issued
Balance (in shares)
Balance (in shares)
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized
Common Stock, Shares Authorized
401(k) Plan
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Comprehensive income
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Total comprehensive loss
Comprehensive Income
Comprehensive Income [Member]
Condensed Financial Statements, Captions [Line Items]
Guarantor Financial Information
Guarantor Financial Information
Consolidation, Eliminations [Member]
Eliminations
Construction in Progress [Member]
Construction in progress
Cost of goods sold
Cost of Goods Sold
Cost of Sales [Member]
Cost of goods sold
Total cost of goods sold
Cost of Revenue
Customer Relationships [Member]
Customer relationships
Variable rate basis
Debt Instrument, Description of Variable Rate Basis
Aggregate principal amount outstanding
Long-term Debt, Gross
Debt Instrument [Line Items]
Financing Arrangements
Schedule of Long-term Debt Instruments [Table]
Debt Instrument, Fair Value Disclosure
Estimated fair value of the debt
Debt Disclosure [Text Block]
Financing Arrangements
Financing Arrangements
Debt Instrument, Basis Spread on Variable Rate
Basis spread on variable rate (as a percent)
Repayment of debt
Debt Instrument, Decrease, Repayments
Debt Instrument, Face Amount
Principal amount of debt
Face value of debt
Debt Instrument, Unamortized Premium
Capitalized premium
Debt Instrument, Increase, Additional Borrowings
Notes issued
Debt Instrument, Interest Rate, Stated Percentage
Interest rate (as a percent)
Deferred Finance Costs, Net
Direct financing fees capitalized
Direct financing fees capitalized
Deferred Finance Costs, Gross
Fees associated with amendment, capitalized
Deferred Finance Costs, Noncurrent, Net
Deferred financing costs
Deferred income taxes
Deferred Income Tax Expense (Benefit)
Deferred tax assets
Deferred Tax Assets, Net of Valuation Allowance, Current
Deferred revenue
Deferred Revenue, Noncurrent
Deferred revenue
Deferred Revenue, Current
Deferred tax assets
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
Deferred tax liability
Deferred Tax Liabilities, Net, Noncurrent
Deferred Tax Liabilities, Net, Current
Deferred tax liability
Depreciation, Depletion and Amortization
Depreciation and amortization
Depreciation
Depreciation
Depreciation expense
Stock-Based Compensation
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock-Based Compensation
Dividends, Common Stock, Cash
Dividend paid to Holdings (see Note 10)
Due from parent
Due from Affiliate, Noncurrent
Due from Related Parties, Noncurrent
Due from parent
Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations
Effect of foreign exchange rate on cash
Employee-related Liabilities, Current
Compensation and benefits
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition
Weighted-average remaining period for recognition of unrecognized compensation costs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense (income) recognized
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options
Total unrecognized compensation costs
Employee Severance [Member]
Severance
Equity Component [Domain]
Estimate of Fair Value, Fair Value Disclosure [Member]
Total fair value
Measurement Frequency [Axis]
Fair Value, Hierarchy [Axis]
Fair Value, Measurements, Recurring [Member]
Recurring basis
Fair Value, Measurement Frequency [Domain]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value, Measurements, Fair Value Hierarchy [Domain]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets measured on recurring basis observable and unobservable inputs
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]
Fair Value, Inputs, Level 3 [Member]
Significant unobservable inputs (Level 3)
Fair Value, Inputs, Level 1 [Member]
Quoted prices in active markets (Level 1)
Fair Value, Inputs, Level 2 [Member]
Significant other observable inputs (Level 2)
Finite-Lived Intangible Asset, Useful Life
Weighted Average Useful Life
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Amortization Expense, Year Five
2016
Finite-Lived Intangible Assets, Gross
Cost
Finite-Lived Intangible Assets [Line Items]
Intangibles, net
Finite-Lived Intangible Assets, Amortization Expense, Year Three
2014
Finite-lived Intangible Assets, Fair Value Disclosure
Fair value of intangible asset
Finite-lived Intangible Assets Acquired
Purchase of U.S., Canadian and Australian territory rights to Ablavar
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Expected future amortization expense related to the intangible assets
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated amortization
Finite-Lived Intangible Assets, Amortization Expense, after Year Five
2017 and thereafter
Finite-Lived Intangible Assets, Amortization Expense, Year Four
2015
Finite-Lived Intangible Assets, Amortization Expense, Year Two
2013
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year
Remainder of 2012
Finite-Lived Intangible Assets, Net
Net
Total
Foreign Currency Transaction Gain (Loss), before Tax
Foreign currency (losses) gains
Gain (Loss) on Disposition of Assets
Loss on disposal of long-lived assets
Gain Contingencies [Line Items]
Legal Proceedings and Contingencies
Gain Contingency, Nature [Domain]
Proceeds from manufacturer
Proceeds from BVL
Gain (Loss) Related to Litigation Settlement
Gain Contingencies [Table]
Gain Contingencies, Nature [Axis]
Loss on early extinguishment of debt
Gains (Losses) on Extinguishment of Debt
General and administrative expenses
General and Administrative Expense
General and Administrative Expense [Member]
General and administrative
Geographic Areas, Revenues from External Customers [Abstract]
Revenues from external customers
Geographical Intersegment, Eliminations [Member]
Inter-segment
Goodwill
Goodwill
Gross profit
Gross Profit
Guarantor Subsidiaries [Member]
Guarantor Subsidiary
Guarantor subsidiary
Impairment of intangible asset
Impairment of Intangible Assets, Finite-lived
Impairment charge
Condensed Consolidated Statements of Comprehensive Loss
Income Taxes
Income Tax Disclosure [Text Block]
Income Taxes
Loss before income taxes
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
(Loss) income before income taxes
Income (Loss) from Equity Method Investments
Equity in earnings (losses) of affiliates
Provision (benefit) for income taxes
Income Tax Expense (Benefit)
Provision for income taxes
Income taxes paid, net of refunds
Income Taxes Paid, Net
Income tax receivable
Income Taxes Receivable, Current
Income tax receivable
Accounts payable
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Accrued expenses and other liabilities
Increase (Decrease) in Due from Related Parties, Current
Due from parent
Income tax payable
Increase (Decrease) in Income Taxes Payable
Increase (Decrease) in Other Noncurrent Liabilities
Long-term income tax payable and other long-term liabilities
Deferred revenue
Increase (Decrease) in Deferred Revenue
Accounts receivable
Increase (Decrease) in Accounts Receivable
Long-term income tax receivable
Increase (Decrease) in Other Noncurrent Assets
Increase (decrease) in cash from operating assets and liabilities
Increase (Decrease) in Operating Capital [Abstract]
Income tax receivable
Increase (Decrease) in Income Taxes Receivable
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Inventory
Increase (Decrease) in Inventories
Increase (Decrease) in Stockholder's Equity
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Insurance Settlement [Member]
Claim against insurance carriers to recover business interruption losses
Intangible Assets Disclosure [Text Block]
Intangibles, net
Intangibles, net
Intangibles, net
Intangible Assets, Net (Excluding Goodwill)
Interest expense, net
Interest Revenue (Expense), Net
Interest Payable, Current
Accrued interest
Interest paid
Interest Paid
Inventory Write-down
Provision for excess and obsolete inventory
Inventory, Finished Goods, Net of Reserves
Finished goods
Inventory, Raw Materials, Net of Reserves
Raw materials
Inventory
Inventory Disclosure [Text Block]
Inventory, Noncurrent
Other long-term assets
Inventory included in other long-term assets
Inventory
Inventory, Net
Inventory
Inventory on-hand
Inventory
Inventory, Work in Process, Net of Reserves
Work in process
Investment Income, Interest
Interest income
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures
Investment in subsidiaries
Unfunded standby Letter of Credit outstanding
Letters of Credit Outstanding, Amount
Long-term Debt, Type [Domain]
Long-term Debt, Type [Axis]
Land [Member]
Land
Legal Proceedings and Contingencies
Legal Matters and Contingencies [Text Block]
Total current liabilities
Liabilities, Current
Current liabilities
Liabilities, Current [Abstract]
Total liabilities
Liabilities
Liabilities and Stockholder's Deficit
Liabilities and Equity [Abstract]
Liabilities and (deficit) equity
Total liabilities and stockholder's deficit
Liabilities and Equity
License and other revenues
License and Services Revenue
Maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Current borrowing capacity
Line of Credit Facility, Current Borrowing Capacity
Current portion of long-term debt
Long-term Debt, Current Maturities
Long-term Debt, Excluding Current Maturities
Long-term debt, net
Long-term debt, net of current portion
Loss on firm purchase commitment
Loss on Contracts
Reserve recorded for loss
Maximum [Member]
Maximum
Minimum [Member]
Minimum
Money Market Funds [Member]
Money market funds
Money Market Funds, at Carrying Value
Money market
Long-Lived Assets
Long-lived Assets
Description of Business
Nature of Operations [Text Block]
Cash flows from financing activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash provided by operating activities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Cash provided by operating activities
Cash flow from operating activities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Increase in cash and cash equivalents
Net Cash Provided by (Used in) Continuing Operations
Increase in cash and cash equivalents
Cash used in investing activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Net Income (Loss) Available to Common Stockholders, Basic
Net loss
Net loss
Net income
Net loss
Cash used in financing activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Cash flows from investing activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Recent Accounting Pronouncements
Non-Guarantor Subsidiaries [Member]
Non-Guarantor Subsidiaries
Noncash investing and financing activities
Noncash Investing and Financing Items [Abstract]
Notes Payable, Current
Note payable
Number of Operating Segments
Number of operating segments
Operating expenses
Operating Expenses [Abstract]
Total operating expenses
Operating Expenses
Reportable segment
Operating Segments [Member]
Operating (loss) income
Operating Income (Loss)
Operating (loss) income
Operating income (loss)
Business Overview
Summary of Significant Accounting Policies
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]
Other
Other Noncash Income (Expense)
Other current assets
Other Assets, Current
Other (Expense) Income, net
Other Assets, Noncurrent
Other long-term assets
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax
Foreign currency translation, net of taxes
Foreign currency translation
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax
Other Income and Other Expense Disclosure [Text Block]
Other (Expense) Income, net
Other Nonoperating Income
Other income
Total other (expense) income, net
Other Nonoperating Income (Expense)
Other (expense) income, net
Other income, net
Other Liabilities, Noncurrent
Other long-term liabilities
Other Accrued Liabilities, Current
Other
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Other comprehensive (loss) income
Other comprehensive income
Parent Company [Member]
Holdings
Lantheus Intermediate
Patents [Member]
Other patents
Accrued Expenses
Debt issuance costs
Payments of Debt Issuance Costs
Payments of deferred financing costs
Payments for Repurchase of Redeemable Preferred Stock
Repurchase of Series A Preferred Stock
Capital expenditures
Payments to Acquire Productive Assets
Payments of Ordinary Dividends, Common Stock
Payment of dividend to parent
Dividend paid
Payment of dividend
Asset acquisition
Purchase of certificate of deposit
Payments to Acquire Restricted Certificates of Deposit
Purchase of certificate of deposit
401(k) Plan
Pension and Other Postretirement Benefits Disclosure [Text Block]
Proceeds from issuance of debt
Proceeds from Issuance of Debt
Proceeds from issuance of debt, net
Due from parent
Proceeds from Contributions from Parent
Proceeds from Lines of Credit
Proceeds from line of credit
Borrowings under line of credit
Proceeds from Dividends Received
Proceeds from dividend
Property, Plant and Equipment, Type [Domain]
Property, Plant and Equipment, net
Property, plant and equipment, net
Property, Plant and Equipment, Net.
Property, plant and equipment, net
Property, Plant and Equipment [Line Items]
Property, plant and equipment
Property, Plant and Equipment, Gross
Property, plant and equipment, gross
Property, Plant and Equipment, Type [Axis]
Property, Plant and Equipment, net
Property, Plant and Equipment Disclosure [Text Block]
Provision for Doubtful Accounts
Provision for bad debt
Cumulative projected future commitments to Nordion
Purchase Obligation
Purchase Commitment, Excluding Long-term Commitment [Axis]
Purchase Commitment, Excluding Long-term Commitment [Domain]
Range [Axis]
Range [Domain]
Due from Parent
Receivables from Stockholder [Member]
Operating (loss) income
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Related Party Transaction [Line Items]
Related Party [Domain]
Related Party Transactions
Related Party [Axis]
Repayments of Lines of Credit
Payments on line of credit
Repayments of line of credit
Payment of term loan
Repayments of Long-term Debt
Payments on term loan
Repayments of Notes Payable
Payments on note payable
Payment of note payable
Research and development expenses
Research and Development Expense
Research and Development Expense [Member]
Research and development
Acquired in-process research and development
Research and Development in Process
Restricted investments
Restricted Cash and Cash Equivalents
Cash and Cash Equivalents [Domain]
Restricted Cash and Cash Equivalents, Current
Restricted investments, current
Restricted Cash and Cash Equivalents, Noncurrent
Restricted investments, noncurrent
Restructuring Type [Axis]
Restructuring Charges
Restructuring charges
Restructuring Reserve
Restructuring reserve
Accumulated deficit
Retained Earnings (Accumulated Deficit)
(Accumulated Deficit) Retained Earnings
Retained Earnings [Member]
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
Revenues from external customers
Revenue from External Customers
Revenues
Total revenues
Revenues
Revenues
Revenues [Abstract]
Revoving Credit
Facility
Revolving Credit Facility [Member]
Revolving Credit
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Exercisable at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Vested and expected to vest at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Expected life
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Outstanding at the beginning of the period
Outstanding at the end of the period
Schedule of expected future amortization expense related to the intangible assets
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Net product revenues
Sales Revenue, Goods, Net
Scenario, Unspecified [Domain]
Schedule of the information about the company's assets and liabilities measured at fair value on a recurring basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Change in Asset Retirement Obligation [Table Text Block]
Schedule of reconciliation of the company's asset retirement obligations
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of option activity
Schedule of Other Nonoperating Income (Expense) [Table Text Block]
Schedule of other income, net
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of assumptions used for estimating the fair value of each option award on the date of grant using a Black-Scholes valuation model
Schedule of Accrued Liabilities [Table Text Block]
Schedule of accrued expenses
Schedule of Finite-Lived Intangible Assets [Table]
Schedule of Condensed Balance Sheet [Table Text Block]
Schedule of Consolidating Balance Sheet Information
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Schedule of intangibles, net
Schedule of Condensed Cash Flow Statement [Table Text Block]
Schedule of Condensed Consolidating Cash Flows Information
Schedule of Cash and Cash Equivalents [Table]
Schedule of Consolidating Operations Information
Schedule of Condensed Income Statement [Table Text Block]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Schedule of Condensed Financial Statements [Table]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Schedule of stock-based compensation expense (income) recognized
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of selected information for each business segment
Schedule of Property, Plant and Equipment [Table]
Valuation and Qualifying Accounts
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Segment, Geographical, Groups of Countries, Group One [Member]
International
Segment Reporting Information [Line Items]
Segment Information
Revenues
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Segment Information
Segment Information
Segment Reporting Disclosure [Text Block]
Segment, Geographical [Domain]
Sales and marketing expenses
Selling and Marketing Expense
Selling and Marketing Expense [Member]
Sales and marketing
9.750% senior subordinated notes due 2017
9.750% Senior Notes
Senior Subordinated Notes [Member]
Stock-based compensation
Share-based Compensation
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted Average Exercise Price
Aggregate fair value of awards vested (in dollars)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Vesting period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Options granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Options granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Options exercised (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Options forfeited or expired (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Expected volatility (as a percent)
Exercisable at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividends (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant-date fair value of options granted (in dollars per share)
Intrinsic value (in dollars)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Additional disclosures
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Exercisable at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Maximum number of shares that may be issued pursuant to awards
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Black-Scholes inputs used for estimating the fair value of each option award on the date of grant
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Options forfeited or expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost
Stock compensation expense associated with the modification of option agreements
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vested and expected to vest at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Outstanding at the beginning of the period
Outstanding at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Vested and expected to vest at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Outstanding at the beginning of the period (in shares)
Outstanding at the end of the period (in shares)
Options outstanding
Award Type [Domain]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Vested and expected to vest at the end of the period (in dollars per share)
Purchase Commitment, Remaining Minimum Amount Committed
Remaining purchase commitment
Statement [Table]
Scenario [Axis]
Statement
Statement [Line Items]
Condensed Consolidated Statements of Stockholder's (Deficit) Equity
Condensed Consolidated Statements of Cash Flows
Equity Components [Axis]
Condensed Consolidated Balance Sheets
Geographical [Axis]
Stock Options [Member]
Stock options
Number of shares of common stock issued
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Options exercised (in shares)
Stockholder's deficit
Stockholders' Equity Attributable to Parent [Abstract]
Total stockholder's deficit
Balance
Balance
Stockholders' Equity Attributable to Parent
(Deficit) Equity
Stockholder's Equity
Stockholder's Equity
Stockholders' Equity Note Disclosure [Text Block]
Balance
Stockholders' Equity, Period Increase (Decrease)
Subsequent Events
Subsequent Events [Text Block]
Subsequent Events
Subsequent Event Type [Domain]
Subsequent Events
Subsequent Event [Line Items]
Subsequent Event Type [Axis]
Subsequent Event [Table]
Subsequent Event
Subsequent Event [Member]
Subsidiary Issuer [Member]
LMI
Supplemental disclosure of cash flow information
Supplemental Cash Flow Information [Abstract]
Transmission Service Agreement [Member]
Transition Services Agreement
Trademarks [Member]
Trademarks
Type of Restructuring [Domain]
Valuation and Qualifying Accounts
Weighted Average
Weighted Average [Member]
Write off of Deferred Debt Issuance Cost
Write-off of deferred financing costs
Centers for Medicare and Medicaid Services [Member]
CMS
Represents the Centers for Medicare and Medicaid Services.
Incremental Reimbursement Amount Per Technetium Dose
Incremental amount, which will be reimbursed for every technetium dose produced
Represents the incremental increase in the amount reimbursed for every technetium dose produced from a generator for a diagnostic procedure in a hospital outpatient setting that is reimbursed by Medicare.
Low Enriched Uranium Percentage Required for Reimbursement
Percentage of low enriched uranium required for production of technetium dose for availing reimbursement
Represents the minimum percentage of low enriched uranium that must be used as a source for Moly contained in generators producing product subject to reimbursement under Medicare.
Incentive Term Period
Period for which the incentive program is expected to be continued
Represents the period for which the incentive program is expected to be continued.
Internal Revenue Service (IRS) [Member]
U.S.
BMS [Member]
Represents activity related to BMS.
BMS
Tax Indemnification Agreement [Member]
Represents activity related to tax indemnification agreements related to certain tax obligations arising prior to acquisition.
Tax Indemnification
Income Tax Contingency [Line Items]
Uncertain tax positions
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations
Tax benefit recognized with the reversal of uncertain tax positions upon expiration of statute of limitations
Unrecognized Tax Benefits
Reversal of taxes payable
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset
Reduction in the indemnification receivable from BMS, included in other expense
Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions
Tax benefit associated with the reversal of uncertain tax positions
Income Tax Contingency [Table]
Income Tax Authority [Axis]
Income Tax Authority [Domain]
Counterparty Name [Axis]
Counterparty Name [Domain]
Contingent Consideration by Type [Axis]
Contingent Consideration Type [Domain]
INC Research LLC [Member]
INC
Represents details pertaining to INC Research LLC, with which a master contract research services agreement has been entered into in relation to flurpiridaz F 18 Phase III program.
Term of Agreement
Agreement term
Represents information pertaining to the term of the agreement.
Clinical Development Services Agreement Related Costs
Costs associated with the agreement
Represents the costs incurred related to the clinical development services agreement.